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tions such as hypertension, ischemic heart disease and dia-
betes.13,14 Resting levels of vWF are higher in patients
with peripheral vascular disease and further increase after
treadmill exercise to claudication,13,15 possibly because of
the endothelial damage induced by ischemia-reperfusion
injury.7,16 The cell adhesion molecule E-selectin is only
found on the endothelium17 and its release in soluble form
in vitro is a sensitive marker of endothelial activation.18
The long-term effects of exercise-induced inflamma-
tory responses in patients with intermittent claudication
are uncertain; however, an enhanced interaction of acti-
vated neutrophils with the vascular endothelium and the
release of toxic oxygen-derived compounds may have
adverse long-term effects and contribute to the excess
morbidity and mortality observed in this patient group.19
We have previously demonstrated that a 6-week program
of upper limb training in patients with intermittent clau-
dication improves cardiovascular fitness and elicits similar
improvements in walking distances to those observed
using a matched lower limb exercise program.20 We
hypothesized that exercising nonischemic muscles (ie, the
arms) would avoid the potentially damaging effects of
neutrophil activation, thereby alleviating some of the con-
cerns associated with lower limb exercise–induced inflam-
matory events. The purpose of the present study was to
examine the acute effects of upper and lower limb exercise
on neutrophil activation and plasma levels of vWF and sol-
A number of studies have demonstrated that walking
exercise training can induce symptomatic improvements in
patients with intermittent claudication,1-5 although the
precise mechanisms underlying the effects are unclear.
Lower limb exercise induces a systemic inflammatory
response that results from the transient reperfusion of
ischemic leg muscles.6,7 One manifestation of this
response is the activation of circulating neutrophils and a
concomitant upregulation in the expression of the cell sur-
face adhesion molecule CD11b.8-11
The systemic inflammatory response may also influ-
ence endothelial damage and activation, as reflected in
plasma levels of von Willebrand factor (vWF) and soluble
E-selectin. Elevated levels of vWF have been proposed to
indicate endothelial damage12 and are present in condi-
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Purpose: We have previously shown that a program of upper limb exercise training can induce significant improvements
in walking distance in patients with claudication. This study assessed whether upper limb exercise avoids the systemic
inflammatory responses associated with lower limb exercise and also whether the inflammatory response to acute lower
limb exertion is modified by a program of supervised exercise training.
Methods: Fifty-two patients with stable intermittent claudication were randomized into two groups who underwent 6
weeks of supervised upper (n = 26) or lower (n = 26) limb cardiorespiratory exercise training. A parallel control group
(n = 15) was provided with lifestyle advice only. Neutrophil activation markers (CD11b and CD66b) and plasma lev-
els of von Willebrand factor (marker of endothelial damage) in response to an acute bout of sustained upper and lower
limb exercise were assessed before and after the period of training. Plasma levels of soluble E-selectin (marker of
endothelial activation) were also determined before and after the training period.
Results: An acute bout of sustained lower limb exercise significantly increased the intensity of CD11b and CD66b
expression by peripheral blood neutrophils in all groups, whereas upper limb exercise had no effect. Resting neutrophil
expression of CD11b and CD66b and circulating von Willebrand factor levels were unaffected by the training program,
as were the inflammatory responses to an acute bout of sustained upper and lower limb muscular work, despite the fact
that both training programs significantly increased walking distances.
Conclusions: These findings indicate that upper limb exercise training programs may offer certain advantages over cur-
rently prescribed lower limb programs. Our results show that exercising nonischemic muscles in a way that promotes
improved cardiorespiratory function and walking capacity can avoid the potentially deleterious systemic inflammatory
responses associated with lower limb exertion in patients with stable intermittent claudication.
(J Vasc Surg 2001;33:392-9.)
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uble E-selectin in the same patient group before and after
this 6-week period of supervised upper or lower limb car-
diorespiratory training.
SUBJECTS AND METHODS
Patients. Sixty-seven subjects (32-85 years of age) with
stable intermittent claudication were recruited from the
Sheffield Vascular Institute at the Northern General Hospital
NHS Trust, Sheffield, UK. Patients were excluded from the
study if they had experienced symptoms for less than 12
months, had undergone a revascularization procedure within
12 months of recruitment, or if they had exercise-limiting
angina, shortness of breath, or severe arthritis. The study
received approval from the North Sheffield Local Research
Ethics Committee, and all subjects gave their informed con-
sent before entering the program.
Patient demographics. The baseline characteristics of
the three subject groups are detailed in Table I. Although
a number of patients had undergone revascularization pro-
cedures, the surgery or angioplasty had been performed
more than a year before recruitment, and they demon-
strated the symptomatic characteristics of intermittent
claudication, as a result of either vessel occlusion or multi-
level disease.
Inflammatory responses to acute exercise. The
inflammatory response to an acute bout of sustained incre-
mental upper and lower limb exercise was assessed before
and after a program of supervised exercise training as
described below by the use of friction-braked arm crank
and leg cycling ergometry (881E arm crank and 824E
cycle ergometer; Monark, Varberg, Sweden). All subjects
were fully familiarized with the ergometry equipment
before entering the study. After 2 minutes of warm-up
against no resistance, the workload was increased by 10 W
(arm cranking) or 25 W (leg cranking) every 3 minutes by
applying a frictional load to the flywheel. Subjects main-
tained a constant crank rate of 50 revolutions · min–1 and
exercise was stopped when the patient was unable to con-
tinue. The work load increments applied in each test
reflect the different muscle mass involved in the cranking
action (arms versus legs) and were determined in prelimi-
nary experiments in patients fulfilling the inclusion and
exclusion criteria of the study. All patients underwent arm
and leg crank assessment regardless of the training pro-
gram to which they were subsequently assigned. Tests
were performed in random order and at least 1 day apart.
Determination of neutrophil activation status.
Peripheral blood neutrophil activation in response to
upper and lower limb exercise was assessed on the basis of
CD11b and CD66b expression as determined by whole
blood flow cytometry. CD11b (Mac-1, complement
receptor 3) is the β subunit of the CD11/CD18 het-
erodimeric complex, which is one of a subfamily of three
cell surface integrin receptors sharing a common β chain
(β2 or CD18). CD11b plays a key role in neutrophil local-
ization at inflammatory sites and its expression is rapidly
upregulated on neutrophil activation.21 CD66b belongs
to the carcinoembryonic family of antigens and is consti-
tutively expressed on neutrophils. It has been implicated
in acute inflammatory conditions such as rheumatoid
arthritis and also in acute thrombosis and atherosclero-
sis.22 CD66b is involved in supporting the action of
CD11b and priming neutrophils for adhesion to the vas-
cular endothelium.23,24 Although CD11b has been used
as a marker of the inflammatory response in patients with
peripheral vascular disease,11 CD66b expression has not
been studied in this group of patients.
Peripheral blood was taken immediately before and 1
hour after incremental exercise ergometry to maximal
exertion. The optimal timing of the blood collection after
exercise was determined in preliminary experiments in a
Table I. Baseline characteristics of the study groups
Variable Untrained (n = 15) Upper limb (n = 26) Lower limb (n = 26) Significance
Sex
Male 9 21 22 NS*
Female 6 5 4
Age (y) (range) 71 (70-77) 68 (63-70) 70 (61-73) NS†
Duration of claudication (mo) (range) 24 (24-36) 24 (18-33) 24 (15-31) NS†
ABPI (range) 0.71 (0.6-0.8) 0.67 (0.6-0.7) 0.64 (0.6-0.8) NS†
Current angina (%) 33 8 15 NS*
Previous myocardial infarction (%) 30 10 15 NS*
Stroke (%) 7 8 8 NS*
Diabetes (%) 26 25 13 NS*
Smokers (%)
Current 13 38 42
Ex 69 51 41 NS*
Non 18 11 17
Cholesterol > 6.5 mmol · L–1 (%) 40 46 50 NS*
Data are from Walker et al.20 Values are median (Q25-Q75). Group differences were determined with the test indicated. Current smoking status was con-
firmed by CO analysis (Smokerlyzer, Bedfont, UK). Diabetic patients were taking oral hypoglycemics or insulin.
*χ2.
†Kruskal-Wallis.
NS, Not significant, P > .05.
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group of five patients with intermittent claudication.
These patients fulfilled the same inclusion criteria as those
recruited to the main study.
All samples were stained immediately as described pre-
viously to avoid ex vivo upregulation of neutrophil activa-
tion antigens.25 Briefly, whole blood (100 µL) was
incubated for 30 minutes at 4°C with 10 µL phycoerythrin-
conjugated anti-CD11b or fluorescein isothiocyanate
(FITC)–conjugated anti-CD66b monoclonal antibody
(Serotec Ltd, Oxford, UK). Control samples were incu-
bated with appropriate FITC- and phycoerythrin-conju-
gated isotype matched nonreactive negative monoclonal
antibodies (Serotec Ltd). Cells were washed, erythrocytes
were lysed with FACSLyse (BD Immuno-cytometry
Systems, Oxford, UK), and the final cell pellet was resus-
pended in the residual volume. Cells were fixed in CellFix
(BD Immunocytometry Systems) and stored in the dark at
4°C until analysis with a FACSort flow cytometer and
CELLQuest data acquisition and analysis software (BD
Immunocytometry Systems).
Polymorphonuclear leukocytes (neutrophils) and
mononuclear lymphocytes exhibit characteristic light scat-
ter properties that can be identified on a forward (FSc)
versus side (SSc) light scatter plot. Neutrophils were
located by using these parameters, and a live analysis gate
was set around this population. Data were acquired from
10,000 cells (events), and both the proportion of neu-
trophils expressing CD11b or CD66b and their median
channel of fluorescent intensity (MCF) were determined.
The MCF was used as an indicator of the antigen density.
Determination of von Willebrand factor and solu-
ble E-selectin levels. Plasma was collected immediately
before and at the end of the exercise training program,
and levels of circulating vWF (as a marker of endothelial
damage) and soluble E-selectin (as a marker of endothelial
activation) were determined by enzyme immunoassay.
vWF levels were determined by using paired capture and
detecting antibodies obtained from Enzyme Research
Laboratories (Swansea, UK) and a highly purified vWF
standard (Alpha Laboratories, Eastleigh, UK). Ninety-
six–well microtiter plates (Nunc Immunoplate MaxiSorp;
Life Technologies, Paisley, UK) were coated by overnight
incubation at 4°C with polyclonal antibody to vWF in car-
bonate buffer pH 9.4 (10 µg/mL). Plates were blocked
with 1% w/v bovine serum albumin in phosphate-buffered
saline containing 1% v/v Tween 20 (PBS/T). After wash-
ing, plasma samples (100 µL; typically diluted 1/50 in
PBS/T) were added and plates incubated for 60 minutes
at room temperature. Bound vWF was detected by using
a polyclonal goat anti-vWF immunoglobulin G antibody
conjugated to horseradish peroxidase, followed by
orthophenyldiamine substrate (Sigma Chemical Co Ltd,
Poole, UK). Absorbance changes were measured at 492
nm by using a Titertek Multiskan MCC/340 Mk II
microplate spectrophotometer (ThermoQuest Scientific
Equipment Group Ltd, Basingstoke, UK). Concentrations
of vWF in plasma samples were determined by reference to
a standard dose response curve (0 to 2.5 µg/mL) by using
ASSAYZAP data analysis software (BIOSOFT, Cambridge,
UK). Soluble E-selectin levels were determined by using a
Diaclone commercial enzyme-linked immunosorbent
assay kit according to the manufacturer’s recommenda-
tions (Immunodiagnostic Systems Ltd, Boldon, UK).
Exercise training programs. After baseline assess-
ment of the inflammatory response to a single bout of arm
and leg cranking exercise, 52 subjects were randomly
assigned to either the lower limb (n = 26) or the upper
limb (n = 26) training group. Supervised exercise training
was undertaken twice a week for a total of 6 weeks, as
described previously.20 The study also included a parallel
control group (n = 15) who were recruited by the use of
identical inclusion and exclusion criteria. This group was
given lifestyle advice, including encouragement to under-
take regular exercise, but did not undertake any formal
supervised training sessions.
The incremental arm cranking and leg cycling assess-
ments that were used to assess the inflammatory response to
acute physical exertion were also used to prescribe training
intensities for the upper and lower limb exercise training
groups, respectively. The penultimate work load achieved in
the respective assessment was used as the initial training
intensity, ensuring that a similar cardiovascular stress was
applied between patients and training modes. For each of
the supervised training sessions, patients trained at this
intensity in cycles of 2-minute exercise followed by 2-
minute rest to give a total exercise time of 20 minutes in
each 40-minute session. Interval training regimens such as
this enable a greater volume of higher intensity work to be
performed in a given amount of time than could be
achieved by using continuous exercise of a similar nature,26
thereby optimizing the stimulus for cardiovascular adapta-
tions. The exercise intensity was increased to the maximum
workload achieved in the respective pretraining assessment
after 3 weeks of training to ensure sufficient stimulus for
continued improvement in cardiovascular fitness.
The amount of work performed by the upper limb
training group was considerably less during training than
was performed by the lower limb training group. At the
beginning of the training period the upper limb group was
training at a median power output of 20 W, whereas the
lower limb group was training at a median power output
of 74 W. Despite these large discrepancies in power out-
put, the level of cardiovascular stress encountered during
training was similar between the upper and lower limb
groups. On the basis of the formula [220 – age] for age-
predicted maximum heart rate, it was shown that both
groups were exercising at an intensity of 75% to 80% pre-
dicted maximum heart rate during the training sessions.
Both the upper and lower limb exercise training regi-
mens have been shown to improve central cardiovascular
function, as indicated by a reduction in the heart rate
response to the same absolute submaximal work loads after
training.20 They have also been shown to induce similar
improvements in the pain-free and maximum walking dis-
tances (Table II), whereas no changes in any of these pa-
rameters were observed in the untrained control group.20
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Statistical methods. Data are presented as medians
and first and third quartiles (Q25 and Q75). The level of
statistical significance was set at a P value of .05. Data typ-
ically displayed skewness and comparisons of variables
between groups were performed with the Mann-Whitney
U test (group data) and the Wilcoxon signed rank test
(paired data) for nonparametric data. Categorical variables
were compared with the χ2 and Kruskal-Wallis tests.
RESULTS
Patient demographics and compliance. Of the 67
subjects recruited into this study, two dropped out from
each of the training groups. One subject developed shin-
gles and another was unable to arrange transport. A third
subject had chronic depression and did not continue
because of anxiety about the training. A fourth subject
dropped out for unknown reasons. Eleven patients had
bilateral symptoms, and the median length of presentation
was 24 months. The median ankle-brachial pressure index
(ABPI) was 0.67 (Table I). All three groups were well
matched for age, risk factors, and ABPI at presentation,
and there were no significant differences in the pretraining
claudication and maximum walking distances (Table II).
As reported previously, attendance at the pretraining and
posttraining assessments was 100% for all three groups,
and attendance at the training sessions was 98% for the
upper limb group and 94% for the lower limb group.20
Neutrophil activation. More than 95% of peripheral
blood neutrophils expressed CD11b and CD66b, and per-
formance of the incremental upper and lower limb exer-
cise assessments had no effect on the proportion of cells
expressing these antigens (data not shown). However,
incremental leg cycling exercise induced a statistically sig-
nificant increase in the intensity of CD11b and CD66b
expression in all three groups of patients (Figs 1, 2, and 3),
whereas arm crank ergometry had no effect (Figs 1, 2, and
3). A period of upper and lower limb training had no
effect on the resting expression of CD11b and CD66b by
peripheral blood neutrophils, as the intensity of expression
at the end of the training program was no different to that
observed at the beginning (Figs 1, 2, and 3).
Furthermore, neither training mode had any effect on the
neutrophil response to incremental leg cycling exercise, as
both CD11b and CD66b expression was significantly
upregulated in response to lower limb exertion after the
period of training in both groups (Figs 1, 2, and 3).
Similarly, neither training mode had any effect on the neu-
trophil response to upper limb work, which remained
unchanged after the period of training in both groups
(Figs 1, 2, and 3).
Circulating levels of von Willebrand factor and sol-
uble E-selectin. The exercise training program had no
effect on resting vWF or soluble E-selectin levels as deter-
mined at the beginning and end of the exercise training
program (Tables III and IV). The acute bouts of incre-
mental arm or leg ergometry did not affect plasma vWF
levels either at the beginning or end of the study period
(data not shown).
DISCUSSION
Walking exercise is routinely prescribed as conservative
therapy for patients with intermittent claudication.
However, we have previously shown that a program of
upper limb cardiorespiratory training can induce similar
symptomatic improvements in patients with intermittent
claudication to those elicited by lower limb training.20
Upper limb exercise induces significant cardiorespiratory
stress (heart rate, intra-arterial blood pressure, and pul-
monary ventilation) for a given absolute level of submaxi-
mal work,26-30 providing an adequate physiologic stimulus
for evoking cardiovascular adaptations. Furthermore,
upper limb exertion is not restricted by the onset of
ischemic pain and may therefore offer a more comfortable
mode of exercise for patients with claudication.
Increased neutrophil expression of CD11b after acute
bouts of lower limb exercise has been demonstrated by
others,11 but as far as we know CD66b has not been inves-
tigated in this setting. CD66b primes and regulates
CD11b-mediated binding to the endothelium,23,31 and it
may be that CD66b is also involved in the ischemia-
reperfusion injury that is induced after exercise in patients
with intermittent claudication. CD66b upregulation is a
marker of neutrophil degranulation whereby the enzymes
lactoferrin and lysozyme are released from secondary gran-
ules.32 It is possible that the release of these enzymes into
the circulation has adverse effects at distant sites and that
the activation of neutrophils and the subsequent release of
toxic products influence endothelial damage and acceler-
Table II. Effect of upper limb and lower limb exercise training on pain-free and maximum walking distances
Pain-free walking distance (m) Maximum walking distance (m)
Before training After training Before training After training
Untrained (n = 15) (range) 142 (108-180) 139 (105-201)* 272 (197-342) 277 (198-345)*
Upper limb (n = 24) (range) 130 (82-220) 287 (175-338)† 267 (188-340) 392 (334-449)†
Lower limb (n = 24) (range) 147 (120-220) 284 (173-294)† 228 (199-341) 341 (275-430)†
Data are from Walker et al.20 Values are median (Q25-Q75). Statistical comparisons of walking distances before and after exercise training were performed
with Wilcoxon rank sum test for paired data.
*NS, Not significant.
†P < .001.
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Fig 1. Effect of arm and leg ergometry exercise on the intensity (as determined by MCF) of CD11b (upper) and CD66b (lower) expres-
sion by peripheral blood neutrophils in the untrained control group at the beginning and end of the study period. Data are medians and
interquartile ranges. Statistical comparisons between preexercise and postexercise values were performed with Wilcoxon signed rank test
and the P values are indicated.
Fig 2. Effect of arm and leg ergometry exercise on the intensity (as determined by MCF) of CD11b (upper) and CD66b (lower) expres-
sion by peripheral blood neutrophils before and after the upper limb exercise training program. Data are medians and interquartile
ranges. Statistical comparisons between preexercise and postexercise values were performed with Wilcoxon signed rank test and the P
values are indicated.
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ated atherosclerosis.6,8,9,11,33-35 Although exercising by
patients with claudication has been shown to increase
intestinal permeability,36 it is difficult to speculate on the
precise clinical sequelae of the inflammatory response to
acute bouts of leg exercise.
Walking training has been reported to reduce the sys-
temic inflammatory response to acute bouts of physical
exertion.7 However, the training regimens used in the pre-
sent study had no effect on the neutrophil response to an
acute bout of lower limb exercise. This is probably due to
the fact that patients exercised either to exhaustion or to
the point of claudication. The acute response might have
been less if blood samples had been drawn earlier in the
final training session at the point when subjects reached
the level of work they had achieved at the end of the ini-
tial assessment.
It is interesting to note that training also had no effect
on resting levels of circulating vWF, which is in contrast to
a previous study in which patients undertook treadmill
exercise.16 It may be that the weight-supported leg exer-
cise used in this study induces less ischemia-reperfusion
than weight-bearing, walking exercise and therefore does
not elicit the same degree of endothelial damage. Our
findings that exercise training had no effect on resting lev-
els of vWF and soluble E-selectin are also in contrast to a
Fig 3. Effect of arm and leg ergometry exercise on the intensity (as determined by MCF) of CD11b (upper) and CD66b (lower) expres-
sion by peripheral blood neutrophils before and after the lower limb exercise training program. Data are medians and interquartile
ranges. Statistical comparisons between pre-exercise and postexercise values were performed with Wilcoxon signed rank test and the P
values are indicated.
Table III. Effect of upper limb and lower limb exercise
training on resting levels of vWF
vWF (µg/mL)
Before training After training
Untrained (n = 14) (range) 7.0 (5.5-8.4) 5.9 (4.9-9.4)
Upper limb (n = 20) (range) 12.1 (9.4-17.1) 10.6 (5.7-14.2)
Lower limb (n = 21) (range) 11.0 (8.0-15.8) 12.0 (8.8-14.8)
Values are median (Q25-Q75). Statistical comparisons of vWF levels before
and after exercise training were performed with Wilcoxon rank sum test for
paired data. Exercise training had no effect on circulating levels of vWF.
Table IV. Effect of upper limb and lower limb exercise
training on resting levels of soluble E-selectin
Soluble E-selectin (ng/mL)
Before training After training
Untrained (n = 13) 51.9 (47.9-64.8) 45.7 (37.5-63.7)
(range)
Upper limb (n = 20) 87.3 (64.1-103.5) 77.7 (58.5-96.8)
(range)
Lower limb (n = 20) 61.2 (47.0-77.5) 61.6 (41.6-81.5)
(range)
Values are median (Q25-Q75). Statistical comparisons of soluble E-selectin
levels before and after exercise training were performed with Wilcoxon
rank sum test for paired data. Exercise training had no effect on baseline
levels of soluble E-selectin.
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study that has reported reduced resting levels of inflam-
matory markers in patients with intermittent claudication
after a 4-week program of combined supervised and non-
supervised leg exercise training.37 However, the two stud-
ies are not directly comparable because resting levels of
vWF and soluble E-selectin were assessed at the end of the
6-week training program in our study, whereas the first
assessment made in the study of Tisi et al was at 3 months
(2 months after the end of the training program). At that
time, the reduction of inflammatory markers was restricted
to C-reactive protein, with fibrinogen and serum amyloid
A protein levels remaining at baseline levels.
Positive adaptations in central cardiovascular function
(at least in the early stages of a training program) are
strongly implicated in the observed improvement in walk-
ing performance.20 The upper limb training regime
resulted in a similar amount of cardiovascular stress as the
lower limb program (75% to 80% predicted maximum
heart rate) but without activating neutrophils and without
causing ischemic pain. Improvement of physical function
through exercise training with nonischemic muscles (ie,
the arms) is likely to be more comfortable for patients with
claudication and may encourage them to exercise at a
greater intensity than would be possible with the more
commonly prescribed walking exercise. Indeed, the appar-
ent central cardiovascular reserve that we have observed in
patients with claudication may reflect the influence of
physical inactivity on cardiac function, perhaps attribut-
able to their avoidance of the physical discomfort associ-
ated with lower limb exertion.
In summary, we have previously demonstrated that a
program of upper limb training leads to an increase in
walking distance in patients with intermittent claudica-
tion.20 In this study we have demonstrated that these
improvements are achieved in the absence of the acute
inflammatory responses associated with walking training
programs. Additional studies are required to determine
which mode of training provides the best clinical benefit
and the least risk.
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LIFELINE FOUNDATION
Request for Clinical Research Grant Applications
Purpose: The Lifeline Foundation is funded through the generosity of the members of the Society for Vascular
Surgery and the American Association for Vascular Surgery, as well as contributions from industry and private
sources. The Foundation has established a special endowment to fund clinical research. One of the mechanisms to
support such research will be the annual funding of investigator-initiated research applications. The purpose of this
program is to stimulate clinical research designed to improve the treatment of patients with vascular disease.
Cooperative clinical research involving multiple practitioners or institutions is encouraged.
Scope: Clinical research is defined broadly and could apply to clinical trials, technology assessment, outcomes
evaluation, etc.
Eligibility: The principal investigator for these applications must be a member of the Society for Vascular
Surgery or the American Association for Vascular Surgery.
Funding: Applications are limited to a maximum duration of 3 years, with maximum direct funding of
$100,000 (or an average of $33,000 per year). No indirect funding will be awarded. It is anticipated that two to
three awards will be made per year. Annual progress reports are required, with continued funding in subsequent
years contingent on satisfactory progress.
Application Process: Applications will be due by March 1 for funding beginning July 1 and on these dates in
subsequent years. Applications may be obtained from The Lifeline Foundation or through its URL at www.vasc-
surg.org/doc/cr_grant_app.html. Seven copies of the application should be returned to: The Lifeline Foundation,
13 Elm Street, Manchester, MA 01944. Applications will follow the format of NIH R01 applications, but the spe-
cific aims, background and significance, preliminary studies and rationale, and research design and methods sec-
tions will be limited to a maximum total of 10 pages.
Review Process: Applications will be reviewed and prioritized by the Technology Assessment and Clinical Trials
Committee. Final selection of award recipients will be made by the Board based on input from this committee.
Award recipients will be announced at the annual meetings of the SVS/AAVS in June. The following factors will
be considered in selecting the award recipients:
1. Significance. If the specific aims of the proposal are achieved, will they provide significant advances in the care
of patients with vascular disease? Is the research likely to have a significant impact on other areas of vascular
research?
2. Approach. Are the research approaches and methods adequately developed, well integrated, and appropri-
ate to the aims of the project? Does the applicant acknowledge potential problem areas and consider alter-
native tactics?
3. Innovation. Does the research propose new approaches or explore new research paradigms or new concepts
that will affect the care of patients with vascular disease? Are current approaches or concepts applied to new
scientific problems in novel ways?
4. Investigators. Are the PI and key personnel appropriately trained and capable of conducting the proposed
research?
5. Environment. Does the scientific and clinical environment in which the work will be done contribute to the
probability of success? Does the proposed research take advantage of unique features of the scientific environ-
ment or employ useful collaborative arrangements? Is there evidence of other support that will contribute to
the success of the research?
